CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity

Journal of Neural Transmission, Supplementa

Volumn , Issue 72, 2007, Pages 159-163

  Viaggi, C ^a   Vaglini, F ^a   Pardini, C ^a   Sgado P ^a   Caramelli, A ^a   Corsini, G U ^a  

^a NONE

Author keywords

CYP 2E1; DDC; MPTP; neurodegeneration; neurotoxicity; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME P450 2E1; DIETHYLDITHIOCARBAMIC ACID; DOPAMINE; NEUROTOXIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG DETOXIFICATION; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HAMSTER; METABOLISM; MOUSE; MOUSE MUTANT; PARKINSONISM; PATHOLOGY; POLYMERASE CHAIN REACTION; PREMEDICATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CRICETINAE; CYTOCHROME P-450 CYP2E1; DITIOCARB; DOPAMINE; DRUG SYNERGISM; METABOLIC DETOXICATION, DRUG; MICE; MICE, KNOCKOUT; NEUROTOXINS; PARKINSONIAN DISORDERS; POLYMERASE CHAIN REACTION; PREMEDICATION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 38449083742     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-73574-9_20     Document Type: Article

References (24)

1. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Proc Natl Acad Sci USA 80(14):45464550
2. Chiba K, Trevor A, Castagnoli NJ (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120(2):574578
3. Corsini GU, Maggio R, Vaglini F (2002) Molecular and cellular events regulating dopamine neuron survival. In: Chiara GD (ed) Handbook of experimental pharmacology. Dopamine in the CNS II, vol 154. Springer, Berlin Heidelberg New York Tokyo, pp 321-386
4. Corsini GU, Pintus S, Chiueh CC, Weiss JF, Kopin IJ (1985) 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate. Eur J Pharmacol 119 (1-2): 127-128
5. Gerlach M, Riederer P (1996) Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103 (8-9): 987-1041
6. Heikkila RE, Sieber BA, Manzino L, Sonsalla PK (1989) Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the mouse. Mol Chem Neuropathol 10(3):171183
7. Johannessen JN, Sobotka TJ, Weise VK, Markey SP (1991) Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) and 40-amino-MPTP are linked to the persistence of pyridinium metabolites. J Neurochem 57(3):981990
8. Kopin IJ (1992) Mechanisms of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine induced destruction of dopaminergic neurons. In: Herken H, Hucho F (eds) Handbook of experimental pharmacology, vol 102. Springer, Berlin Heidelberg New York Tokyo, pp 333-356
9. Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ (1996) Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem 271(20):1206312067
10. Lieber CS (1990) Mechanism of ethanol induced hepatic injury. Pharmacol Ther 46(1):141
11. Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77(2):517544
12. Markey SP, Johannessen JN, Chiueh CC, Burns RS, Herkenham MA (1984) Intraneuronal generation of a pyridinium metabolite may cause druginduced parkinsonism. Nature 311(5985):464467
13. Miksys SL, Tyndale RF (2002) Drug-metabolizing cytochrome P450s in the brain. J Psychiat Neurosci 27(6):406415
14. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. Life Sci 36(26):25032508
15. Nissbrandt H, Bergquist F, Jonason J, Engberg G (2001) Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse 40(4):294301
16. Parkinson A (1996) Biotransformation of xenobiotics. In: Klaassen CD (ed) Casarett and Doull's toxicology: the basic science of poisons, 5th edn. McGraw-Hill Education (ISE Editions), New York, pp 113-186
17. Ramsay RR, Singer TP (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, by mitochondria. J Biol Chem 261(17):75857587
18. Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS (1986) Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: a neurochemical and morphological reassessment. Brain Res 376(1):117124
19. Schneider JS, Markham CH (1986) Neurotoxic effects of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry. Brain Res 373 (1-2): 258-267
20. Sonsalla PK, Nicklas WJ (1992) MPTP animal models of Parkinson's disease. In: Koller WC (ed) Handbook of Parkinson's disease. Marcel Dekker, New York, pp 319-340
21. Stott I, Murthy A, Robinson A, Thomas NW, Fry JR (1997) Low-dose diethyldithiocarbamate attenuates the hepatotoxicity of 1, 3-dichloro-2-propanol and selectively inhibits CYP2E1 activity in the rat. Hum Exp Toxicol 16(5):262266
22. Vaglini F, Pardini C, Viaggi C, Bartoli C, Dinucci D, Corsini GU (2004) Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced mouse model of Parkinson's disease. J Neurochem 91(2):285298
23. Warner M, Wyss A, Yoshida S, Gustafsson JA (1994) Cytochrome P450 enzymes in the brain. In: De Kloet RE, Sutanto W (eds) Methods in neurosciences. Neurobiology of steroids, vol 22. Academic Press, New York, pp 51-66
24. Zuddas A, Oberto G, Vaglini F, Fascetti F, Fornai F, Corsini GU (1992) MK-801 prevents 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in primates. J Neurochem 59(2):733739